Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial - Kahl, S; Gancheva, S; Straßburger, K (Diabetes Care, 2020)